Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
0.100 | Biomarker | phenotype | HPO | |||||||
|
0.100 | Biomarker | phenotype | HPO | |||||||
|
0.100 | Biomarker | phenotype | HPO | |||||||
|
0.100 | Biomarker | phenotype | HPO | |||||||
|
0.100 | Biomarker | phenotype | HPO | |||||||
|
0.100 | Biomarker | phenotype | HPO | |||||||
|
0.100 | Biomarker | phenotype | HPO | |||||||
|
0.100 | Biomarker | phenotype | HPO | |||||||
|
0.100 | Biomarker | phenotype | HPO | |||||||
|
0.100 | Biomarker | phenotype | HPO | |||||||
|
0.100 | Biomarker | phenotype | HPO | |||||||
|
0.100 | GeneticVariation | phenotype | CLINVAR | |||||||
|
0.100 | Biomarker | phenotype | HPO | |||||||
|
0.100 | Biomarker | phenotype | HPO | |||||||
|
0.100 | Biomarker | phenotype | HPO | |||||||
|
0.100 | Biomarker | phenotype | HPO | |||||||
|
0.100 | Biomarker | phenotype | HPO | |||||||
|
0.100 | Biomarker | phenotype | HPO | |||||||
|
0.100 | Biomarker | phenotype | HPO | |||||||
|
0.100 | Biomarker | phenotype | HPO | |||||||
|
0.100 | Biomarker | phenotype | HPO | |||||||
|
0.300 | Biomarker | phenotype | GENOMICS_ENGLAND | Variants in myelin regulatory factor (MYRF) cause autosomal dominant and syndromic nanophthalmos in humans and retinal degeneration in mice. | 31048900 | 2019 | ||||
|
0.300 | Biomarker | phenotype | GENOMICS_ENGLAND | Autosomal dominant nanophthalmos and high hyperopia associated with a C-terminal frameshift variant in MYRF. | 31700225 | 2019 |